← Back to Clinical Trials
Recruiting NCT06907654

NCT06907654 Couples' Affect in Relationships Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06907654
Status Recruiting
Phase —
Sponsor University of Wisconsin, Madison
Condition Depression Disorders
Study Type INTERVENTIONAL
Enrollment 2,000 participants
Start Date 2026-08-04
Primary Completion 2028-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
well-being appList of well-being resources

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 2,000 participants in total. It began in 2026-08-04 with a primary completion date of 2028-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to find out whether learning about well-being impacts the thoughts and feelings of romantic couples. The main question it aims to answer is: * Does gaining knowledge about well-being positively impact individuals and their romantic relationships? Participants will complete online surveys about their thoughts and feelings.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years * Be either married, living together, OR in a dating relationship for at least 12 months * Proficiency in English * US citizen or permanent resident * If non-monogamous, must be able to enroll in the study with a primary partner with whom they spend the majority of their time. * Use of a smartphone (primary participant only) * Phone able to receive SMS text messages * Depression symptoms (≥ 5 on PHQ-9; primary participant only) Exclusion Criteria: * Severe physical or sexual relationship aggression during the past 6 months (any item endorsement on 5-item severe IPV screener) * Endorsement of active suicidality * History of psychosis or mania * Prior use of the Healthy Minds Program app * Prior significant experience with meditation * Severe hearing impairment that would interfere with the use of an audio-based intervention (primary participant only) * Did not pass video attention check * Investigators may also track the time it takes for participants to complete surveys and use survey timing as a method to flag for suspicious bot activity * Participant presents false or misleading information or other indicators that the participant may be participating in the study in bad faith. At screening, each participant's address will be checked and they will be excluded if the address is 1) invalid or 2) a non-residential address. Participants will also be excluded if the same email is provided for both partners. Participants will be excluded if they fail the attention check item in the baseline survey. Participants will be excluded if they complete their screeners \<= 20 minutes of each other.

Contact & Investigator

Central Contact
Principal Investigator

Simon Goldberg, PhD

PRINCIPAL INVESTIGATOR

University of Wisconsin, Madison

Frequently Asked Questions

Who can join the NCT06907654 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Depression Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06907654 currently recruiting?

Yes, NCT06907654 is actively recruiting participants. Contact the research team at cares@chm.wisc.edu for enrollment information.

Where is the NCT06907654 trial being conducted?

This trial is being conducted at Madison, United States.

Who is sponsoring the NCT06907654 clinical trial?

NCT06907654 is sponsored by University of Wisconsin, Madison. The principal investigator is Simon Goldberg, PhD at University of Wisconsin, Madison. The trial plans to enroll 2,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology